Insider Trading Alert - ORM, JMI And ELGX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 27, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $945.00 to $3,999,999.00.

Highlighted Stocks Traded by Insiders:

Owens Realty Mortgage (ORM) - FREE Research Report

Platt Melina A, who is Controller at Owens Realty Mortgage, bought 750 shares at $13.08 on May 27, 2015. Following this transaction, the Controller owned 2,410 shares meaning that the stake was boosted by 45.18% with the 750-share transaction.

The shares most recently traded at $13.07, down $0.01, or 0.08% since the insider transaction. Historical insider transactions for Owens Realty Mortgage go as follows:

  • 4-Week # shares bought: 3,600
  • 12-Week # shares bought: 3,600
  • 24-Week # shares bought: 3,600

The average volume for Owens Realty Mortgage has been 28,100 shares per day over the past 30 days. Owens Realty Mortgage has a market cap of $140.8 million and is part of the financial sector and real estate industry. Shares are down 9.76% year-to-date as of the close of trading on Wednesday.

Owens Realty Mortgage, Inc., a real estate investment trust, focuses on the origination, investment, and management of commercial real estate loans primarily in the Western United States. The stock currently has a dividend yield of 2.14%. The company has a P/E ratio of 42.2.

Exclusive Offer: Get the latest Stock Analysis on ORM - FREE

TheStreet Quant Ratings rates Owens Realty Mortgage as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full Owens Realty Mortgage Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

JAVELIN Mortgage Investment (JMI) - FREE Research Report

Zimmer Jeffrey J, who is Co-CEO and President at JAVELIN Mortgage Investment, bought 10,000 shares at $7.41 on May 27, 2015. Following this transaction, the Co-CEO and President owned 41,775 shares meaning that the stake was boosted by 31.47% with the 10,000-share transaction.

Ulm Scott, who is Co-CEO and CIO at JAVELIN Mortgage Investment, bought 10,000 shares at $7.39 on May 27, 2015. Following this transaction, the Co-CEO and CIO owned 42,525 shares meaning that the stake was boosted by 30.75% with the 10,000-share transaction.

The shares most recently traded at $7.49, up $0.10, or 1.37% since the insider transaction. Historical insider transactions for JAVELIN Mortgage Investment go as follows:

  • 4-Week # shares bought: 20,000
  • 12-Week # shares bought: 44,000
  • 24-Week # shares bought: 59,250

The average volume for JAVELIN Mortgage Investment has been 123,600 shares per day over the past 30 days. JAVELIN Mortgage Investment has a market cap of $88.5 million and is part of the financial sector and real estate industry. Shares are down 27.68% year-to-date as of the close of trading on Wednesday.

JAVELIN Mortgage Investment Corp., a real estate investment trust (REIT), invests primarily in fixed rate agency, and fixed rate and hybrid adjustable rate non-agency residential mortgage-backed securities in the United States. The company qualifies as a REIT for federal income tax purposes. The stock currently has a dividend yield of 14.63%. Currently, there are no analysts who rate JAVELIN Mortgage Investment a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JMI - FREE

TheStreet Quant Ratings rates JAVELIN Mortgage Investment as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full JAVELIN Mortgage Investment Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Endologix (ELGX) - FREE Research Report

Wilder Thomas, who is Director at Endologix, sold 3,790 shares at $16.08 on May 27, 2015. Following this transaction, the Director owned 14,553 shares meaning that the stake was reduced by 20.66% with the 3,790-share transaction.

The shares most recently traded at $16.43, up $0.35, or 2.13% since the insider transaction. Historical insider transactions for Endologix go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 1,872
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 46,872
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 56,872

The average volume for Endologix has been 560,300 shares per day over the past 30 days. Endologix has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are up 8.18% year-to-date as of the close of trading on Wednesday.

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. Currently, there are 2 analysts who rate Endologix a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ELGX - FREE

TheStreet Quant Ratings rates Endologix as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Endologix Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip